SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001472375-24-000074
Filing Date
2024-08-07
Accepted
2024-08-07 12:13:20
Documents
45
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT FOR THE PERIOD ENDED JUNE 30, 2024 ixform10q.htm   iXBRL 10-Q 378005
2 CERTIFICATION exhibit31-1.htm EX-31.1 11292
3 CERTIFICATION exhibit31-2.htm EX-31.2 11619
4 CERTIFICATION exhibit32-1.htm EX-32.1 4463
5 CERTIFICATION exhibit32-2.htm EX-32.2 4438
6 regenerexlogo.gif GRAPHIC 5716
  Complete submission text file 0001472375-24-000074.txt   2209648

Data Files

Seq Description Document Type Size
7 SCHEMA DOCUMENT rgpx-20240630.xsd EX-101.SCH 20174
8 CALCULATION LINKBASE DOCUMENT rgpx-20240630_cal.xml EX-101.CAL 30874
9 DEFINITION LINKBASE DOCUMENT rgpx-20240630_def.xml EX-101.DEF 100911
10 LABELS LINKBASE DOCUMENT rgpx-20240630_lab.xml EX-101.LAB 163656
11 PRESENTATION LINKBASE DOCUMENT rgpx-20240630_pre.xml EX-101.PRE 140412
47 EXTRACTED XBRL INSTANCE DOCUMENT ixform10q_htm.xml XML 153117
Mailing Address 5348 VEGAS DRIVE, SUITE 177 LAS VEGAS NV 89108
Business Address 5348 VEGAS DRIVE, SUITE 177 LAS VEGAS NV 89108 305-927-5191
REGENEREX PHARMA, INC. (Filer) CIK: 0001357878 (see all company filings)

IRS No.: 980479983 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-53230 | Film No.: 241182483
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)